Skip to content
Screener

Roivant Sciences ROIV Non-Controlling Interests

Non-Controlling Interests at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$0-100%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$26.25B+244%
Enterprise value$26.28B+244%
P/S3,485×+3,157×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0×0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemJune 30, 2026March 31, 2026
Common shares, par value $0.0000000341740141 per share, 7,000,000,000 shares authorized and 722,668,062 and 720,352,386 shares issued and outstanding at June 30, 2026 and March 31, 2026, respectively——
Additional paid-in capital5,130,9265,024,826
Accumulated deficit(900,354)(501,814)
Accumulated other comprehensive income7014,358
Shareholders’ equity attributable to Roivant Sciences Ltd.4,231,2734,527,370
Noncontrolling interests690,596765,042
Total shareholders’ equity4,921,8695,292,412
Total liabilities and shareholders’ equity$5,306,493$5,708,687

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's non-controlling interests?
Roivant Sciences (ROIV) reported non-controlling interests of $690.6M in Q2 2026.
How has Roivant Sciences's non-controlling interests changed year-over-year?
Roivant Sciences's non-controlling interests increased by 46.9% year-over-year, from $470.27M to $690.6M.
What is the long-term trend for Roivant Sciences's non-controlling interests?
Over 5 years (2020 to 2025), Roivant Sciences's non-controlling interests has grown at a 25.9% compound annual growth rate (CAGR), from $241.73M to $765.04M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.

Ask your AI about Roivant Sciences's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude